Disordered follicle development

Molecular and Cellular Endocrinology

Volumn 373, Issue 1-2, 2013, Pages 51-60

  Chang, R Jeffrey ^a   Cook Andersen, Heidi ^a  

^a University of California San Diego   (United States)

Author keywords

Androgen; Follicle; Granulosa cell; Insulin; PCOS; Theca cell

Indexed keywords

ANDROGEN; CHORIONIC GONADOTROPIN; FOLLITROPIN; GONADORELIN AGONIST; INSULIN; LEUPRORELIN; PIOGLITAZONE;

ANDROGEN SYNTHESIS; CELL DEGENERATION; CELL HYPERPLASIA; DRUG MEGADOSE; GRANULOSA CELL; HUMAN; LOW DRUG DOSE; NONHUMAN; OVARY FOLLICLE; OVARY FOLLICLE CELL; OVARY FOLLICLE DEVELOPMENT; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; REVIEW; SINGLE DRUG DOSE; STEROIDOGENESIS; THECA CELL;

ANDROGENS; ANIMALS; ANTI-MULLERIAN HORMONE; ESTROGENS; FEMALE; FOLLICLE STIMULATING HORMONE; GRANULOSA CELLS; HUMANS; INSULIN; LUTEINIZING HORMONE; OVARIAN FOLLICLE; OVULATION; POLYCYSTIC OVARY SYNDROME;

EID: 84878114696     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.07.011     Document Type: Review

References (81)

1. Adashi E.Y., Hsueh A.J.W. Estrogens augment the stimulation of ovarian aromatase activity by follicle-stimulating hormone in cultured rat granulosa cells. J. Biol. Chem. 1982, 257:6077-6083.
2. Almahbobi G., Anderiesz C., Hutchinson P., McFarlane J.R., Wood C., Trounson A.O. Functional integrity of granulosa cells from polycystic ovaries. Clin. Endocrinol. 1996, 44:571-580.
3. Barbieri R.L., Makris A., Ryan K.J. Insulin stimulates androgen accumulation in incubations of human ovarian stroma and theca. Obstet. Gynecol. 1984, 64:73S-80S.
4. Barbieri R.L., Makris A., Randall R.W., Daniels G., Kistner R.W., Ryan K.J. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J. Clin. Endocrinol. Metab. 1986, 62:904-910.
5. Barnes R.B., Rosenfield R.L., Burstein S., Ehrmann D.A. Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. N. Engl. J. Med. 1989, 320:559-565.
6. Barnes R.B., Rosenfield R.L., Ehrmann D.A., Cara J.F., Cuttler L., Levitsky L.L., Rosenthal I.M. Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. J. Clin. Endocrinol. Metab. 1994, 79:1328-1333.
7. Bergh C., Carlsson B., Olsson J.H., Selleskog U., Hillensjo T. Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin. Fertil. Steril. 1993, 59:323-331.
8. Bremer A.A., Miller W.L. The serine phosphorylation hypothesis of polycystic ovary syndrome: a unifying mechanism for hyperandrogenemia and insulin resistance. Fertil. Steril. 2008, 89:1039-1048.
9. Cara J.F., Rosenfield R.L. Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells. Endocrinology 1988, 123:733-739.
10. Chadha S., Pache T.D., Huikeshoven F.J.M., Brinkmann A.O., van der Kwast T.H. Androgen receptor expression in human ovarian and uterine tissue of long term androgen-treated transsexual women. Human Path. 1994, 25:1198-1204.
11. Chang R.J., Mandel F.P., Lu J.K., Judd H.L. Enhanced disparity of gonadotropin secretion by estrone in women with polycystic ovarian disease. J. Clin. Endocrinol. Metab. 1982, 54:490-494.
12. Coffler M.S., Patel K.S., Dahan M.H., Malcom P.J., Kawashima T., Deutsch R., Chang R.J. Evidence for abnormal granulosa cell responsiveness to follicle stimulating hormone in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2003, 88:1742-1747.
13. Coffler M.S., Patel K.S., Dahan M.H., Yoo R.Y., Malcom P.J., Chang R.J. Enhanced granulosa cell responsiveness to follicle stimulating hormone during insulin infusion in women with polycystic ovary syndrome treated with pioglitazone. J. Clin. Endocrinol. Metab. 2003, 88:5624-5631.
14. Daniel S., Armstrong D. Enhancement of follicle-stimulating hormone-induced aromatase activity by androgens in cultured rat granulosa cells. Endocrinology 1980, 107:1027-1033.
15. Daniel S.A., Armstrong D.T. Involvement of estrogens in the regulation of granulosa cell aromatase activity. Can. J. Physiol. Pharmacol. 1983, 61:507-511.
16. Davoren J.B., Kasson B.G., Li C.H., Hsueh A.J. Specific insulin-like growth factor (IGF) I- and II-binding sites on rat granulosa cells: relation to IGF action. Endocrinology 1986, 119:2155-2162.
17. de Ziegler D., Steingold K., Cedars M., Lu J.K., Meldrum D.R., Judd H.L., Chang R.J. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease. J. Clin. Endocrinol. Metab. 1989, 68:1111-1117.
18. Dong J., Albertini D.F., Nishimori K., Kumar T.R., Lu N., Matzuk M.M. Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 1996, 383:531-535.
19. Dooley C.A., Attia G.R., Rainey W.E., Moore D.R., Carr B.R. Bone morphogenetic protein inhibits ovarian androgen production. J. Clin. Endocrinol. Metab. 2000, 85:3331-3337.
20. Dunaif A., Graf M. Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome. J. Clin. Invest. 1989, 83:23-29.
21. Dunaif A., Scully R.E., Andersen R.N., Chapin D.S., Crowley W.F. The effects of continuous androgen secretion on the hypothalamic-pituitary axis in women: evidence from a luteinized thecoma of the ovary. J. Clin. Endocrinol. Metab. 1984, 59:389-393.
22. Dunaif A., Xia J., Book C.B., Schenker E., Tang Z. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. J. Clin. Invest. 1995, 96:801-810.
23. Erickson G.F., Hsueh A.J. Stimulation of aromatase activity by follicle stimulating hormone in rat granulosa cells in vivo and in vitro. Endocrinology 1978, 102:1275-1282.
24. Erickson G.F., Yen S.S.C. New data on follicle cells in polycystic ovaries: a proposed mechanism for the genesis of cystic follicles. Semin. Reprod. Endocrinol. 1984, 2:231-243.
25. Erickson G.F., Magoffin D.A., Jones K.L. Theca function in polycystic ovaries of a patient with virilizing congenital adrenal hyperplasia. Fertil. Steril. 1989, 51:173-176.
26. Erickson G.F., Magoffin D.A., Cragun J.R., Chang R.J. The effects of insulin and insulin-like growth factors-I and -II on estradiol production by granulosa cells of polycystic ovaries. J. Clin. Endocrinol. Metab. 1990, 70:894-902.
27. Fanchin R., Schonauer L.M., Righini C., Frydman N., Frydman R., Taieb J. Serum anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation. Hum. Reprod. 2003, 18:328-332.
28. Franks S., Stark J., Hardy K. Follicle dynamics and anovulation in polycystic ovary syndrome. Hum. Reprod. Update 2008, 14:367-378.
29. Futterweit W., Deligdisch L. Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals. J. Clin. Endocrinol. Metab. 1986, 62:16-21.
30. Gilling-Smith C., Willis D.S., Beard R.W., Franks S. Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. J. Clin. Endocrinol. Metab. 1994, 79:1158-1165.
31. Gilling-Smith C., Story H., Rogers V., Franks S. Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome. Clin. Endocrinol. 1997, 47:93-99.
32. Glister C., Richards S.L., Knight P.G. Bone morphogenetic proteins (BMP) -4, -6, and -7 potently suppress basal and luteinizing hormone-induced androgen production by bovine theca interna cells in primary culture: could ovarian hyperandrogenic dysfunction be caused by a defect in thecal BMP signaling?. Endocrinology 2005, 146:1883-1892.
33. Grossman M.P., Nakajima S.T., Fallat M.E., Siow Y. Mullerian-inhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture. Fertil. Steril. 2008, 89:1364-1370.
34. Harlow C., Hillier S., Hodges J. Androgen modulation of follicle-stimulating hormone-induced granulosa cell steroidogenesis in the primate ovary. Endocrinology 1986, 119:1403-1405.
35. Hillier S., De Zwart F. Evidence that granulosa cell aromatase induction/activation by follicle- stimulating hormone is an androgen receptor-regulated process in-vitro. Endocrinology 1981, 109:1303-1305.
36. Hillier S.G., Yong E.L., Illingworth P.J., Baird D.T., Schwall R.H., Mason A.J. Effect of recombinant inhibin on androgen synthesis in cultured human thecal cells. Mol. Cell. Endocrinol. 1991, 75:R1-6.
37. Hirshfeld-Cytron J., Barnes R.B., Ehrmann D.A., Caruso A., Mortensen M.M., Rosenfield R.L. Characterization of functionally typical and atypical types of polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2009, 94:1587-1594.
38. Hughesdon P.E. Morphology and morphogenesis of the Stein-Leventhal ovary and of so- called "hyperthecosis". Obstet. Gynecol. Surv. 1982, 37:59-77.
39. Jakimiuk A.J., Weitsman S.R., Navab A., Magoffin D.A. Luteinizing hormone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overexpressed in thecal and granulosa cells from polycystic ovaries. J. Clin. Endocrinol. Metab. 2001, 86:1318-1323.
40. Jia X.C., Kessel B., Welsh T.H., Hsueh A.J. Androgen inhibition of follicle-stimulating hormone-stimulated luteinizing hormone receptor formation in cultured rat granulosa cells. Endocrinology 1985, 117:13-22.
41. Jonassen J.A., Bose K., Richards J.S. Enhancement and desensitization of hormone-responsive adenylate cyclase in granulosa cells of preantral and antral ovarian follicles: effects of estradiol and follicle-stimulating hormone. Endocrinology 1982, 111:74-79.
42. Kaiser U., Sabbagh E., Katzenellenbogen R., Conn P., Chin W. A mechanism for the differential regulation of gonadotropin subunit gene expression by gonadotropin-releasing hormone. Proc. Natl. Acad. Sci. USA 1995, 92:12280-12284.
43. Knecht M., Darbon J.-M., Ranta T., Baukal A.J., Catt K.J. Estrogens enhance the adenosine 3', 5'-monophosphate-mediated induction of follicle-stimulating hormone and luteinizing hormone receptors in rat granulosa cells. Endocrinology 1984, 115:41-49.
44. La Marca A., Malmusi S., Giulini S., Tamaro L.F., Orvieto R., Levratti P., Volpe A. Anti-Müllerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation. Hum. Reprod. 2004, 19:2738-2741.
45. Laven J.S., Imani B., Eijkemans M.J., de Jong F.H., Fauser B.C. Absent biologically relevant associations between serum inhibin B concentrations and characteristics of polycystic ovary syndrome in normogonadotrophic anovulatory infertility. Hum. Reprod. 2001, 16:1359-1364.
46. Lewis K.A., Gray P.C., Blount A.L., MacConell L.A., Wiater E., Bilezikjian L.M., Vale W. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling. Nature 2000, 404:411-414.
47. Lindeberg M., Carlstrom K., Ritvos O., Hovatta O. Gonadotrophin stimulation of non-luteinized granulosa cells increases steroid production and the expression of enzymes involved in estrogen and progesterone synthesis. Hum. Reprod. 2007, 22:401-406.
48. Maciel G.A., Baracat E.C., Benda J.A., Markham S.M., Hensinger K., Chang R.J., Erickson G.F. Stockpiling of transitional and classic primary follicles in ovaries of women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2004, 89:5321-5327.
49. Magoffin D.A., Jakimiuk A.J. Inhibin A, inhibin B and activin A concentrations in follicular fluid from women with polycystic ovary syndrome. Hum. Reprod. 1998, 13:2693-2698.
50. Mason H.D., Willis D.S., Beard R.W., Winston R.M., Margara R., Franks S. Estradiol production by granulosa cells of normal and polycystic ovaries: relationship to menstrual cycle history and concentrations of gonadotropins and sex steroids in follicular fluid. J. Clin. Endocrinol. Metab. 1994, 79:1355-1360.
51. May J.V., McCarty K., Reichert L.E., Schomberg D.W. Follicle-stimulating hormone-mediated induction of functional luteinizing hormone/human chorionic gonadotropin receptors during monolayer culture of porcine granulosa cells. Endocrinology 1980, 107:1041-1049.
52. Mehta R.V., Malcom P.J., Chang R.J. The effect of androgen blockade on granulosa cell estradiol production after follicle-stimulating hormone stimulation in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2006, 91:3503-3506.
53. Nahum R., Thong K.J., Hillier S.G. Metabolic regulation of androgen production by human thecal cells in vitro. Hum. Reprod. 1995, 10:75-81.
54. Nelson V.L., Legro R.S., Strauss J.F., McAllister J.M. Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Mol. Endocrinol. 1999, 13:946-957.
55. Nestler J.E., Clore J.N., Strauss J.F., Blackard W.G. The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans. J. Clin. Endocrinol. Metab. 1987, 64:180-184.
56. Pellatt L., Hanna L., Brincat M., Galea R., Brain H., Whitehead S., Mason H. Granulosa cell production of anti-Mullerian hormone is increased in polycystic ovaries. J. Clin. Endocrinol. Metab. 2007, 92:240-245.
57. Rebar R., Judd H.L., Yen S.S., Rakoff J., Vandenberg G., Naftolin F. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J. Clin. Invest. 1976, 57:1320-1329.
58. Richards J.S. Maturation of ovarian follicles: actions and interactions of pituitary and ovarian hormones on follicular cell differentiation. Physiol. Rev. 1980, 60:51-89.
59. Richards J.S. Hormonal control of gene expression in the ovary. Endocr. Rev. 1994, 15:725-751.
60. Richards J.S., Ireland J.J., Rao M.C., Bernath G.A., Midgley A.R.J., Reichert L.E.J. Ovarian follicular development in the rat: hormone receptor regulation by estradiol, follicle stimulating hormone and luteinizing hormone. Endocrinology 1976, 99:1562-1570.
61. Richards J.S., Jonassen J.A., Rolfes A.I., Kersey K., Reichert L.E. Adenosine 3',5'-monophosphate, luteinizing hormone receptor, and progesterone during granulosa cell differentiation: effects of estradiol and follicle-stimulating hormone. Endocrinology 1979, 104:765-773.
62. Rosencrantz M.A., Coffler M.S., Haggan A., Duke K.B., Donohue M.C., Shayya R.F., Su H.I., Chang R.J. Clinical evidence for predominance of Delta-5 steroid production in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2011, 96:1106-1113.
63. Rosenfield R.L., Barnes R.B., Ehrmann D.A. Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism. J. Clin. Endocrinol. Metab. 1994, 79:1686-1692.
64. Rotterdam, 2004a. ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril. 81, 19-25.
65. Rotterdam, 2004b. ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Hum. Reprod. 19, 41-47.
66. Sanders M.M., Midgley A.R. Rat granulosa cell differentiation: an in vitro model. Endocrinology 1982, 111:614-624.
67. Shimasaki S., Moore R.K., Otsuka F., Erickson G.F. The bone morphogenetic protein system in mammalian reproduction. Endocr. Rev. 2004, 25:72-101.
68. Spinder T., Spijkstra J.J., van den Tweel J.G., Burger C.W., van Kessel H., Hompes P.G., Gooren L.J. The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects. J. Clin. Endocrinol. Metab. 1989, 69:151-157.
69. Stubbs S.A., Hardy K., Da Silva-Buttkus P., Stark J., Webber L.J., Flanagan A.M., Themmen A.P., Visser J.A., Groome N.P., Franks S. Anti-mullerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries. J. Clin. Endocrinol. Metab. 2005, 90:5536-5543.
70. Teixeira Filho F.L., Baracat E.C., Lee T.H., Suh C.S., Matsui M., Chang R.J., Shimasaki S., Erickson G.F. Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2002, 87:1337-1344.
71. Vendola K.A., Zhou J., Adesanya O.O., Weil S.J., Bondy C.A. Androgens stimulate early stages of follicular growth in the primate ovary. J. Clin. Invest. 1998, 101:2622-2629.
72. Wachs D.S., Coffler M.S., Malcom P.J., Chang R.J. Comparison of follicle-stimulating-hormone-stimulated dimeric inhibin and estradiol responses as indicators of granulosa cell function in polycystic ovary syndrome and normal women. J. Clin. Endocrinol. Metab. 2006, 91:2920-2925.
73. Wachs D.S., Coffler M.S., Malcom P.J., Shimasaki S., Chang R.J. Increased androgen response to follicle-stimulating hormone administration in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2008, 93:1827-1833.
74. Webber L.J., Stubbs S., Stark J., Trew G.H., Margara R., Hardy K., Franks S. Formation and early development of follicles in the polycystic ovary. Lancet 2003, 362:1017-1021.
75. Webber L.J., Stubbs S.A., Stark J., Margara R.A., Trew G.H., Lavery S.A., Hardy K., Franks S. Prolonged survival in culture of preantral follicles from polycystic ovaries. J. Clin. Endocrinol. Metab. 2007, 92:1975-1978.
76. Weenen C., Laven J.S., Von Bergh A.R., Cranfield M., Groome N.P., Visser J.A., Kramer P., Fauser B.C., Themmen A.P. Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol. Hum. Reprod. 2004, 10:77-83.
77. Weil S., Vendola K., Zhou J., Bondy C.A. Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. J. Clin. Endocrinol. Metab. 1999, 84:2951-2956.
78. Welt C.K., Taylor A.E., Fox J., Messerlian G.M., Adams J.M., Schneyer A.L. Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B biosynthesis. J. Clin. Endocrinol. Metab. 2005, 90:5582-5587.
79. Wiater E., Vale W. Inhibin is an antagonist of bone morphogenetic protein signaling. J. Biol. Chem. 2003, 278:7934-7941.
80. Willis D., Mason H., Gilling-Smith C., Franks S. Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J. Clin. Endocrinol. Metab. 1996, 81:302-309.
81. Willis D.S., Watson H., Mason H.D., Galea R., Brincat M., Franks S. Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation. J. Clin. Endocrinol. Metab. 1998, 83:3984-3991.